In 2021-22, Covid19 business was almost 20-22% of the revenue for most diagnostic companies. The non-Covid19 business is not going to grow by 22% to make it equal
The share of retail deposits would rise and help keep net interest margins intact, Sanjiv Chadha, managing director and chief executive of Bank of Baroda, says
Appointment completes quorum at anti-trust regulator, enables it to tackle pending cases
When asked if the 50% increase was high, he replied: "Yes. But at least you are getting the stuff (chips). It is obviously at the cost of someone else"
ONGC is keen to work with global majors as strategic partners in challenging areas, said Sushma Rawat, director (exploration) of the company
'Our insulin portfolio today offers best-in-class insulin for better diabetes management'
'We are talking of a practical solution and not digging our heels in saying 'we don't have to pay you a rupee'
'We talk about India in every board meeting'
'The bank is adequately capitalised. But in case of need, we have taken enabling provisions from the board and shareholders'
This is not the story of just Amrita Chemicals, but of around 400-odd downstream units, 40-odd contractors and even transport companies
'Central bank digital currency (CBDC) and Digital Rupee open up exciting opportunities and if implemented correctly'
The fintech giant, in its Q4 results for FY23, managed to narrow its losses to Rs 168 crore
According to analysts, YouTube brings in roughly Rs 8,000 crore or about a third of this topline
Target that we have set is 60 gigawatts (Gw) of renewables by 2032. The broader objective is that our renewables should be as large as or close to our coal-based portfolio by 2032 - Bhargava
'The factors behind the Go First crisis were beyond its control'
'We have planned a capex of Rs 16,000 crore. Of this, roughly, Rs 4,000 crore is in Europe, with the Netherlands accounting for about Rs 3,000; the balance will be in the UK'
'In the commodity business, it is volume that matters. We have grown 16 per cent annually'
"The broader objective is that our renewables portfolio should be as large or as close to our coal-based portfolio by 2050," said NTPC Green Energy CEO Mohit Bhargava
The problems facing Risher are an offshoot of pandemic-driven restrictions that dramatically curtailed travel during most of 2020 and much of 2021, shrivelling demand for rides on Uber and Lyft
There have been no thrombotic events reported to date for the 8 mg dose and USFDA has not placed the 8 mg dose on hold, the drugmaker said in a regulatory filing